Picture of Tianjin Development Holdings logo

882 — Tianjin Development Holdings News Story

0.000.00%
hk flag iconLast trade - 00:00
UtilitiesConservativeSmall CapNeutral

Brief: Tianjin Development Says Qtrly Net Profit Attributable Of Tianjin Lisheng Pharmaceutical RMB46.5 Mln

April 27 (Reuters) - Tianjin Lisheng Pharmaceutical Co
Ltd  002393.SZ :
    * QTRLY NET PROFIT ATTRIBUTABLE OF TIANJIN LISHENG
PHARMACEUTICAL
CO RMB46.5 MILLION VERSUS RMB42 MILLION
    * QTRLY TOTAL OPERATING INCOME OF TIANJIN LISHENG
PHARMACEUTICAL
CO RMB335.6 MILLION VERSUS RMB306.5 MILLION

Source text for Eikon:  ID:nHKSN4mG8 
Further company coverage:  002393.SZ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Tianjin Development Holdings

See all news